Tarsus Pharmaceuticals Inc (TARS) — Working Capital to Net Assets Ratio
Tarsus Pharmaceuticals Inc (TARS) has a Working Capital to Net Assets ratio of 111.4% as of June 2026. Working capital of $386.24 Million (current assets of $561.99 Million minus current liabilities of $175.75 Million) is measured against net assets of $346.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Tarsus Pharmaceuticals Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tarsus Pharmaceuticals Inc Working Capital to Net Assets (2018–2025)
This chart shows how Tarsus Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 111.4%, reflecting working capital of $386.24 Million against net assets of $346.73 Million USD. For the complete balance sheet picture, see balance sheet size of Tarsus Pharmaceuticals Inc.
Annual Working Capital to Net Assets for Tarsus Pharmaceuticals Inc (2018–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tarsus Pharmaceuticals Inc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Tarsus Pharmaceuticals Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 112.7% | $387.09 Million | $343.43 Million | $522.78 Million | $135.69 Million | ▼ -10.2 pp |
| 2024 | 123.0% | $276.09 Million | $224.53 Million | $356.70 Million | $80.61 Million | ▲ +11.7 pp |
| 2023 | 111.3% | $219.19 Million | $196.99 Million | $256.13 Million | $36.94 Million | ▲ +2.4 pp |
| 2022 | 108.8% | $209.95 Million | $192.90 Million | $225.38 Million | $15.43 Million | ▲ +10.2 pp |
| 2021 | 98.6% | $164.47 Million | $166.73 Million | $175.95 Million | $11.48 Million | ▼ -0.9 pp |
| 2020 | 99.6% | $165.27 Million | $165.98 Million | $170.66 Million | $5.39 Million | ▲ +1052.3 pp |
| 2019 | -952.7% | $57.21 Million | $-6.00 Million | $58.03 Million | $819.00K | ▼ -789.9 pp |
| 2018 | -162.8% | $2.20 Million | $-1.35 Million | $2.38 Million | $179.00K | — |